FOUNDATION FOR THE ACCREDITATION OF CELLULAR THERAPY

What FOUNDATION FOR THE ACCREDITATION OF CELLULAR THERAPY does

The Foundation for the Accreditation of Cellular Therapy (FACT) is a non-profit accreditation organization headquartered in Omaha, Nebraska, that establishes peer-developed quality and safety standards for cellular therapy programs worldwide. FACT's core product is its accreditation program, which validates that cellular therapy providers—including hospitals, medical centers, and specialized clinics delivering blood and bone marrow transplants, immune effector cell therapies, and other cell-based treatments—meet minimum quality thresholds across the full patient journey from collection to administration. Supporting the accreditation offering, FACT operates a portfolio of platforms and services: the FACT Accreditation Portal (application and document management), the Learning and Development Academy (live, online, and on-demand training), FACT Consulting Services (preparation support), and the FACT Store (publications and standards documents), along with specialized resource centers covering Quality Management, Data Management, Clinical Outcomes, and Immune Effector Cells, including CAR-T therapies.

FACT monetizes through a multi-stream revenue model including accreditation fees (application, inspection, and annual maintenance, classified as subscription/recurring), fee-based consulting (professional services), course/training fees from the Learning Academy (subscription/recurring), and e-commerce sales through the FACT Store (one-time license). Its go-to-market is hybrid: digital self-service channels (accreditation portal, e-commerce storefront, online learning) combined with field-based engagement via a global network of trained volunteer inspectors who conduct on-site facility evaluations worldwide. Customer segmentation is vertical, with primary customers being cellular therapy programs and secondary customers including cord blood banks and other healthcare accreditation bodies. Pricing is not publicly disclosed; organizations must contact FACT directly or access the portal for fee schedules.

The organization's competitive position rests on brand recognition as the leading accreditation body specifically for cellular therapy, peer-developed standards recognized as a de facto industry benchmark, and a community ecosystem of expert volunteer inspectors and accredited organizations. FACT operates as an independent non-profit foundation governed by its board of directors, with no disclosed funding history, M&A activity, executive leadership transitions, or AI/ML capabilities. The geographic footprint is global with on-site inspector coverage worldwide, and primary operations are concentrated at the Omaha headquarters.

Name

FOUNDATION FOR THE ACCREDITATION OF CELLULAR THERAPY

Legal name

The Foundation for the Accreditation of Cellular Therapy

Website

https://factwebsite.org

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

11–50 employees

Short description

FACT is a non-profit organization that develops peer-reviewed quality and safety standards and provides accreditation for cellular therapy programs globally, serving hospitals, transplant centers, cord blood banks, and related providers.

Ownership category

akta.pro rank

Product category

Healthcare Accreditation Services

NAICS

Other Professional, Scientific, and Technical Services (5419), Blood and Organ Banks (621991)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Standards, Metrology & Accreditation Bodies (BPAIAOAC)

akta.pro secondary industries

Laboratory Quality Systems, Accreditation & Proficiency Testing Programs (HLAJAIAM), Cell Therapy Quality, Analytics & Release Testing (potency, sterility, comparability) (HLAAABAK)

Keywords

• Cellular therapy accreditation
• Quality standards compliance
• Healthcare accreditation services
• Professional education training
• Clinical quality management

Headquarters

HQ city

Omaha

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Accreditation Services: FACT generates revenue through accreditation fees charged to cellular therapy programs and organizations seeking FACT accreditation. Organizations pay for the accreditation process, including application fees, inspection fees, and annual maintenance fees.
2. FACT Consulting Services: Fee-based consulting services offered to organizations seeking guidance on meeting FACT Standards and preparing for accreditation.
3. Learning Academy: Educational programs and training offered through the Learning and Development Academy, providing revenue from course fees and training programs for cellular therapy professionals.
4. FACT Store: E-commerce storefront selling FACT publications, standards documents, forms, and resources to the cellular therapy community.

Go-to-market motion4 records

Distribution channels5 records

Marketing channels6 records

Core offering

FACT develops and maintains peer-developed standards defining minimum quality and safety thresholds for cellular therapy, and awards accreditation to cellular therapy programs that comply with those standards. Supporting fee-based offerings include FACT Consulting Services to help organizations prepare for accreditation, the Learning and Development Academy for professional education, and the FACT Store for standards publications and forms.

Product overview

FACT offers a platform-based accreditation ecosystem centered on FACT Standards and Accreditation. The core offering consists of peer-developed cellular therapy quality and safety standards paired with an accreditation program that validates compliance. Supporting modules include FACT Consulting Services for preparation support, the Learning Academy for professional education, the Accreditation Portal for process management, the FACT Store for publications, and specialized Resource Centers covering Quality Management, Data Management, Clinical Outcomes, and Immune Effector Cells. The portfolio also includes a volunteer inspector program that enables peer review of accredited programs.

Differentiator

Problem solved

Functional benefit

Products and services

• FACT Accreditation Independent third-party accreditation program that validates cellular therapy programs (including blood and bone marrow transplant, immune effector cell therapy, and cord blood banking programs) meet peer-developed FACT Standards, signaling commitment to ongoing quality improvement.
• FACT Consulting Services Fee-based advisory and consulting engagements that help cellular therapy organizations prepare for and achieve FACT Accreditation, identify gaps against FACT Standards, and implement quality improvements.
• FACT Learning and Development Academy Online educational platform offering live, online, and on-demand training courses for cellular therapy professionals covering FACT Standards, quality management, and accreditation preparation.
• FACT Store E-commerce storefront selling FACT publications, standards documents, forms, and resource materials to the cellular therapy community.
• FACT Accreditation Portal Web-based portal through which organizations apply for FACT Accreditation, submit required documentation, and manage and track their accreditation status throughout the accreditation lifecycle.
• FACT Inspector Program Volunteer inspector program in which trained peer professionals conduct on-site evaluations of cellular therapy programs as part of the accreditation process.

Quantifiable outcome

• Accreditation signals commitment to ongoing quality improvement and reducing variability in care

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• The Joint Commission: The largest healthcare accreditation body in the United States, accrediting thousands of hospitals and healthcare programs. While FACT specializes narrowly in cellular therapy, The Joint Commission operates in the broader healthcare accreditation space and was specifically referenced as an adjacent accreditation partner in FACT's customer segments.
• Clinical Laboratory Improvement Amendments (CLIA) / CMS: CMS administers CLIA, the federal regulatory program that certifies clinical laboratories in the United States. CLIA sets baseline regulatory requirements that complement — and partially overlap with — FACT accreditation for cellular therapy laboratories.

Direct peers

• AABB (Association for the Advancement of Blood & Biotherapies): AABB accredits blood banks, transfusion services, and cellular therapy programs, making it the most direct competitor to FACT in cellular therapy and cord blood banking accreditation. Both organizations set standards for collection, processing, and storage of cellular products.
• College of American Pathologists (CAP): CAP is a major laboratory accreditation body whose Laboratory Accreditation Program is widely required for clinical labs. Cellular therapy programs often hold both FACT and CAP accreditation, making CAP a directly comparable peer in laboratory quality accreditation.
• JACIE (Joint Accreditation Committee of ISCT and EBMT): JACIE is the European counterpart to FACT, providing accreditation for hematopoietic stem cell transplantation and cellular therapy programs. FACT and JACIE even operate a joint accreditation pathway (FACT-JACIE), making JACIE the closest direct peer in the cellular therapy accreditation category.
• American Society for Histocompatibility & Immunogenetics (ASHI): ASHI accredits histocompatibility and immunogenetics laboratories that support solid organ and hematopoietic stem cell transplantation. Its accreditation activities overlap with FACT's transplant-related cellular therapy scope, particularly for bone marrow transplant programs.

Emerging players

• International Society for Cell & Gene Therapy (ISCT): ISCT is a professional society that co-owns JACIE (the European cellular therapy accreditation body) and shapes global standards in cell and gene therapy. It is comparable as a standards-setting and community-building organization in the same cellular therapy ecosystem where FACT operates.
• Foundation for the Accreditation of Regenerative Medicine (FARM): A newer accreditation organization focused on regenerative medicine and advanced therapy products, representing a potential emerging competitor to FACT as the field expands beyond traditional cellular therapy into regenerative and tissue-engineered products.

Market position

Strengths4 records

Weaknesses3 records

Competitive moat4 records

Key risks4 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about FOUNDATION FOR THE ACCREDITATION OF CELLULAR THERAPY